Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Topiroxostat (FYX-051) is a selective xanthine oxidase inhibitor developed for treatment and management of hyperuricemia and gout.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 43.00 | |
25 mg | In stock | $ 64.00 | |
50 mg | In stock | $ 97.00 | |
100 mg | In stock | $ 169.00 | |
200 mg | In stock | $ 217.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 48.00 |
Description | Topiroxostat (FYX-051) is a selective xanthine oxidase inhibitor developed for treatment and management of hyperuricemia and gout. |
Targets&IC50 | XOR:5.3 nM |
Synonyms | FYX-051 |
Molecular Weight | 248.24 |
Formula | C13H8N6 |
CAS No. | 577778-58-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 11 mg/mL (44.31 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Topiroxostat 577778-58-6 Immunology/Inflammation Metabolism P450 ROS Xanthine Oxidase CYPs Inhibitor Cytochrome P450 FYX051 hyperuricemia Asn 768 inhibit uric XOR acid FYX 051 pharmacokinetic FYX-051 CYP3A4 inhibitor